Amanote Research

Amanote Research

    RegisterSign In

Should Patient Groups Accept Money From Drug Companies? Yes

BMJ
doi 10.1136/bmj.39185.461968.ad
Full Text
Open PDF
Abstract

Available in full text

Date

May 3, 2007

Authors
Alastair Kent
Publisher

BMJ


Related search

Should My Patient Accept a Kidney From a Hepatitis C Virus–Infected Donor?

Kidney360
2020English

Should Doctors Use Drug Companies' Starter Packs?

BMJ
1983English

Should Clinicians Accept Management Responsibilities?

Postgraduate Medical Journal
Medicine
1992English

Should Physicians Attempt to Persuade a Patient to Accept a Compromised Organ for Transplant?

AMA journal of ethics
Health PolicyEthicsHealthIssuesLegal Aspects
2016English

Should Physicians Attempt to Persuade a Patient to Accept a Compromised Organ for Transplant?

AMA journal of ethics
Health PolicyEthicsHealthIssuesLegal Aspects
2016English

Drug Companies Should Report Side Effects in Terms of Frequency

BMJ
1996English

Should Red Cell Transfusion Be Individualized? Yes

Intensive Care Medicine
Critical CareIntensive Care Medicine
2015English

Should Geriatric Medicine Remain a Specialty? Yes

BMJ
2008English

Should Genetic Information Be Disclosed to Insurers? Yes

BMJ
2007English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2025 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy